BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29738536)

  • 1. Statins impact primary embryonic mouse neural stem cell survival, cell death, and fate through distinct mechanisms.
    Carson RA; Rudine AC; Tally SJ; Franks AL; Frahm KA; Waldman JK; Silswal N; Burale S; Phan JV; Chandran UR; Monaghan AP; DeFranco DB
    PLoS One; 2018; 13(5):e0196387. PubMed ID: 29738536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase.
    Kato S; Smalley S; Sadarangani A; Chen-Lin K; Oliva B; Brañes J; Carvajal J; Gejman R; Owen GI; Cuello M
    J Cell Mol Med; 2010 May; 14(5):1180-93. PubMed ID: 19432822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins).
    Eberlein M; Heusinger-Ribeiro J; Goppelt-Struebe M
    Br J Pharmacol; 2001 Aug; 133(7):1172-80. PubMed ID: 11487529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
    Lee MH; Cho YS; Han YM
    Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells.
    Saito A; Saito N; Mol W; Furukawa H; Tsutsumida A; Oyama A; Sekido M; Sasaki S; Yamamoto Y
    Melanoma Res; 2008 Apr; 18(2):85-94. PubMed ID: 18337644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pravastatin on type IV collagen secretion and mesangial cell proliferation.
    Nishimura M; Tanaka T; Yasuda T; Kurakata S; Kitagawa M; Yamada K; Saito Y; Hirai A
    Kidney Int Suppl; 1999 Jul; 71():S97-100. PubMed ID: 10412748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin.
    Thelen KM; Rentsch KM; Gutteck U; Heverin M; Olin M; Andersson U; von Eckardstein A; Björkhem I; Lütjohann D
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1146-52. PubMed ID: 16282522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.
    Ogunwobi OO; Beales IL
    Am J Gastroenterol; 2008 Apr; 103(4):825-37. PubMed ID: 18371146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase.
    Cohen LH; van Vliet A; Roodenburg L; Jansen LM; Griffioen M
    Biochem Pharmacol; 1993 Jun; 45(11):2203-8. PubMed ID: 8517861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin and simvastatin, but not pravastatin, up-regulate LPS-induced MMP-9 expression in macrophages by regulating phosphorylation of ERK and CREB.
    Lee DK; Park EJ; Kim EK; Jin J; Kim JS; Shin IJ; Kim BY; Lee H; Kim DE
    Cell Physiol Biochem; 2012; 30(3):499-511. PubMed ID: 22814256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geranylgeranylpyrophosphate plays a key role for the G1 to S transition in vascular smooth muscle cells.
    Terano T; Shiina T; Noguchi Y; Tanaka T; Tatsuno I; Saito Y; Yasuda T; Kitagawa M; Hirai A
    J Atheroscler Thromb; 1998; 5(1):1-6. PubMed ID: 10077451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct effects of pravastatin, atorvastatin, and simvastatin on insulin secretion from a beta-cell line, MIN6 cells.
    Ishikawa M; Okajima F; Inoue N; Motomura K; Kato T; Takahashi A; Oikawa S; Yamada N; Shimano H
    J Atheroscler Thromb; 2006 Dec; 13(6):329-35. PubMed ID: 17192698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geranylgeranylpyrophosphate, a metabolite of mevalonate, regulates the cell cycle progression and DNA synthesis in human lymphocytes.
    Tatsuno I; Tanaka T; Oeda T; Yasuda T; Kitagawa M; Saito Y; Hirai A
    Biochem Biophys Res Commun; 1997 Dec; 241(2):376-82. PubMed ID: 9425279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of acetylcholine activated potassium current (I KACh) by simvastatin, not pravastatin in mouse atrial cardiomyocyte: possible atrial fibrillation preventing effects of statin.
    Cho KI; Cha TJ; Lee SJ; Shim IK; Zhang YH; Heo JH; Kim HS; Kim SJ; Kim KL; Lee JW
    PLoS One; 2014; 9(10):e106570. PubMed ID: 25329899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) induce hepatic expression of the phospholipid translocase mdr2 in rats.
    Hooiveld GJ; Vos TA; Scheffer GL; Van Goor H; Koning H; Bloks V; Loot AE; Meijer DK; Jansen PL; Kuipers F; Müller M
    Gastroenterology; 1999 Sep; 117(3):678-87. PubMed ID: 10464145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro.
    Demyanets S; Kaun C; Pfaffenberger S; Hohensinner PJ; Rega G; Pammer J; Maurer G; Huber K; Wojta J
    Biochem Pharmacol; 2006 Apr; 71(9):1324-30. PubMed ID: 16540096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins impair survival of primary human mesenchymal progenitor cells via mevalonate depletion, NF-κB signaling, and Bnip3.
    Li Y; Müller AL; Ngo MA; Sran K; Bellan D; Arora RC; Kirshenbaum LA; Freed DH
    J Cardiovasc Transl Res; 2015 Mar; 8(2):96-105. PubMed ID: 25547946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of Simvastatin-Induced Inhibition of Tendon Cell Proliferation and Cell Cycle Progression by Geranylgeranyl Pyrophosphate.
    Tsai WC; Yu TY; Lin LP; Cheng ML; Chen CL; Pang JH
    Toxicol Sci; 2016 Feb; 149(2):326-34. PubMed ID: 26577051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical effects of statins on aortic valve myofibroblasts and osteoblasts: implications for end-stage valvular heart disease.
    Wu B; Elmariah S; Kaplan FS; Cheng G; Mohler ER
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):592-7. PubMed ID: 15618546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.